| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $12.2B | $11.1B | $9.9B | $8.4B | $6.0B |
| Cost of Revenue | $2.1B | $1.9B | $1.7B | $1.5B | $1.2B |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $2.4B | $2.1B | $1.7B | $1.5B | $1.4B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $2.5B | $2.6B | $1.5B | $1.8B | $0.4B |
| Net Income | $2.5B | $2.6B | $4.8B | $1.9B | $-0.4B |
| EPS (Basic) | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $22.2B | $21.0B | $20.6B | $16.0B | $13.7B |
| Current Assets | $18.8B | $17.2B | $16.5B | $14.9B | $12.4B |
| Cash & Equivalents | $6.6B | $6.9B | $6.9B | $7.4B | $6.1B |
| Total Liabilities | $14.0B | $12.5B | $12.5B | $10.5B | $8.9B |
| Current Liabilities | $13.6B | $10.2B | $9.9B | $8.0B | $6.4B |
| Stockholders' Equity | $8.2B | $8.4B | $8.2B | $5.6B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.6B | $4.5B | $3.9B | $3.4B | $2.2B |
| Investing Cash Flow | $-0.7B | $-0.6B | $-1.0B | $-0.0B | $-1.4B |
| Capital Expenditures | — | — | — | $0.0B | $0.0B |
| Financing Cash Flow | $-3.8B | $-3.6B | $-2.4B | $-0.7B | $1.4B |